Quest Diagnostics Incorporated Price Today
Quest Diagnostics Incorporated
DGX
Healthcare
$15.19B
๐ฐ
Market Cap
19.6
๐ธ
Price to Earnings
$6.9
๐
EPS
+0
๐ณ
ESG
Consensus Recommendations
Hold Consensus
Buy |
4 |
Strong Buy |
3 |
Hold |
16 |
Sell |
0 |
Strong Sell |
0 |
DGX Price Forecast Target
135.7 ๐ 165.0 +22%
DGX EPS Forecast
6.9 ๐ 9.1 +31%
Financials
Profit Margin
8 %
Revenue Growth
-4.7 %
Dividend
$ 2.84
Held Percent
0.8% - Insiders
92.9% - Institutions
6.3% - Public
Major Fund Holders
-
๐ฐ Vanguard Group Inc $1.9B
-
๐ฐ Blackrock Inc. $1.7B
-
๐ฐ State Street Corporation $803.0M
-
๐ฐ Victory Capital Management Inc. $454.5M
-
๐ฐ American Century Companies, Inc. $386.1M
Stock Ideas
George Soros Portfolio
George Soros is a legendary hedge fund manager who made history when he earned 1 billion in 1992 and became known as 'the Man Who Broke the Bank of England'. "With an estimated net worth of 14.2 billion, Soros is ranked 35th on the list of the worldโฆChristopher Hohn Portfolio
Christopher Hohn is a British hedge fund manager and philanthropist. He founded The Children's Investment Fund Management in 2003, one of Europe's largest hedge funds. Known for his activist investment approach, Hohn targets undervalued companies wiโฆDaniel Sundheim Portfolio
Daniel Sundheim is the founder of D1 Capital Partners, a renowned multi-billion dollar global investment firm. Prior to starting his own firm, Sundheim worked as a portfolio manager at prestigious hedge funds before breaking out on his own in 2018. โฆDaniel Loeb Portfolio
Daniel Loeb is an American billionaire businessman and founder/CEO of Third Point LLC, a global investment firm managing over $12 billion in assets through long/short equity investments and activism. As one of the world's most successful hedge fundโฆ๐ฎFAQ
Some Frequently Asked Questions.
The Quest Diagnostics Incorporated industry is Diagnostics & Research
The Quest Diagnostics Incorporated sector is Healthcare
The Quest Diagnostics Incorporated forecasted predicted Price to Earnings PE ratio is 14.9
The Quest Diagnostics Incorporated Price to Earnings PE ratio is 19.6
The Market Capitalization of Quest Diagnostics Incorporated is $15.19B
There are total of 111269778 float shares with 92.9% held by Institutions and 0.8% held by insiders
The MQuest Diagnostics Incorporated forecasted Earnings per Share EPS is $9.1
The Quest Diagnostics Incorporated Earnings per Share EPS is 6.9
The Quest Diagnostics Incorporated company has $3467000000 gross profits with 8 profit margins
The Quest Diagnostics Incorporated Earnings Growth is 0.046% with 0.004% quarterly earnings growth
The Quest Diagnostics Incorporated Revenue is $9488000000 with -0.047 revenue growth
The price target for Quest Diagnostics Incorporated stock is $165.0 for the high target and $140.0 for the low target
The consensus analyst recommendations for Quest Diagnostics Incorporated is Hold, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Quest Diagnostics Incorporated is Hold, with the following breakdown:
- Buy: 4
- Strong Buy: 3
- Hold: 16
- Sell: 0
- Strong Sell: 0
The Beta of Quest Diagnostics Incorporated is 0.9
The dividend of Quest Diagnostics Incorporated is $2.84
The dividend yield of Quest Diagnostics Incorporated is 0.0209%
The biggest institutional and mutual fund holders of Quest Diagnostics Incorporated stock are
- Vanguard Group Inc
- Blackrock Inc.
- State Street Corporation
- Victory Capital Management Inc.
The Quest Diagnostics Incorporated ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0